Gene polymorphisms identified that are responsible for breast density and cancer risk

October 24, 2012

It has long been known that breast density, or mammographic density, is a strong risk factor for breast cancer, and that estrogen and progestin hormone therapy increases dense breast tissue. Now, a study published in BioMed Central's open access journal Breast Cancer Research has identified several gene variants in hormone metabolism and growth factor pathways that may be associated with breast density and, hence, breast cancer risk.

Mammographic density relates to the fact that x-rays permeate different types of breast tissue in different ways, leading to white areas on the mammogram. Fatty tissue appears on the mammogram as relatively translucent, whereas dense breast tissue contains more stromal tissue and , appearing as white areas. Women with a breast density of 75% or more have a 4-5 times higher risk of developing than women of the same age with little or no density.

Controversy exists over why breast density is a cancer risk. Many studies suggest that density is at least partially inherited, and twin studies show that genetic factors do play a role in the variation observed. Breast density decreases naturally with older age and menopause, but also increases with hormone therapy. Merete Ellingjord-Dale and co-authors, from academic centers in Norway and Los Angeles, set out to investigate which genes could play a role in determining breast density. Because of the clear involvement of hormones, they were looking particularly for genes involved in hormone metabolism.

Using data from 2,036 women who participated in the Norwegian Program in 2004, and separating the participants into hormone therapy users and non-users, the authors found that different gene variants appeared to be important depending on the women's hormone therapy usage.

There was evidence to suggest that variants in the prolactin (PRL) gene were associated with breast density in users of estrogen and progestin, as well as norethisterone acetate (a common regimen in Nordic countries). In non-users of hormone therapy, variants in the tumor necrosis factor (TNF) and SULT1A1/2 genes were significantly associated with breast density.

The findings suggest that several genes in hormone metabolism and growth factor pathways are indeed implicated in determining , and might increase . Commenting on the findings, lead author, Merete Ellingjord-Dale said, "One reason it has been so difficult to pinpoint which genes are responsible for mammographic density is that the effect of some genetic variants may be amplified in combination with hormone therapy. Consequently in the presence of hormone therapy these genes cause increased density."

She continued, "It is important to consider both the genetic and non-genetic factors simultaneously. Exploring the functional role of gene variants associated with mammographic density could further clarify the biological mechanisms involved. "

Explore further: Breast tenderness in women getting combo hormone therapy associated with increase in breast density

Related Stories

Breast tenderness in women getting combo hormone therapy associated with increase in breast density

October 14, 2011
Post-menopausal women who experience new onset breast tenderness after starting combination hormone therapy may have an increased risk of breast cancer compared to women who don't experience breast tenderness, a study by ...

Breast tenderness linked to increased breast density

October 24, 2011
(Medical Xpress) -- Post-menopausal women who experience breast tenderness after starting combination hormone therapy have a higher risk of breast cancer than women who don't, a study by researchers with UCLA's Jonsson Comprehensive ...

Breast density does not influence breast cancer death among breast cancer patients

August 20, 2012
The risk of dying from breast cancer was not related to high mammographic breast density in breast cancer patients, according to a study published August 20 in the Journal of the National Cancer Institute.

Breast density tied to specific types of breast cancer

July 27, 2011
Women with breasts that appear dense on mammograms are at a higher risk of breast cancer and their tumors are more likely to have certain aggressive characteristics than women with less dense breasts, according to a study ...

Breast cancer patients with high density mammograms do not have increased risk of death

September 7, 2012
(Medical Xpress)—High mammographic breast density, which is a marker of increased risk of developing breast cancer, does not seem to increase the risk of death among breast cancer patients, according to a study led by Gretchen ...

Recommended for you

CAR-T immunotherapy may help blood cancer patients who don't respond to standard treatments

October 20, 2017
Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis is one of the first centers nationwide to offer a new immunotherapy that targets certain blood cancers. Newly approved ...

Researchers pinpoint causes for spike in breast cancer genetic testing

October 20, 2017
A sharp rise in the number of women seeking BRCA genetic testing to evaluate their risk of developing breast cancer was driven by multiple factors, including celebrity endorsement, according to researchers at the University ...

Study shows how nerves drive prostate cancer

October 19, 2017
In a study in today's issue of Science, researchers at Albert Einstein College of Medicine, part of Montefiore Medicine, report that certain nerves sustain prostate cancer growth by triggering a switch that causes tumor vessels ...

Gene circuit switches on inside cancer cells, triggers immune attack

October 19, 2017
Researchers at MIT have developed a synthetic gene circuit that triggers the body's immune system to attack cancers when it detects signs of the disease.

One to 10 mutations are needed to drive cancer, scientists find

October 19, 2017
For the first time, scientists have provided unbiased estimates of the number of mutations needed for cancers to develop, in a study of more than 7,500 tumours across 29 cancer types. Researchers from the Wellcome Trust Sanger ...

Researchers target undruggable cancers

October 19, 2017
A new approach to targeting key cancer-linked proteins, thought to be 'undruggable," has been discovered through an alliance between industry and academia.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.